Skip to main content
. 2017 Jun 5;14:36. doi: 10.1186/s12977-017-0360-7

Table 4.

In vitro and in vivo selection of de novo non-canonical INSTI resistance substitutions in HIV IN in tissue culture and in INSTI-naïve individuals

Substitutions RAL EVG DTG CTG BIC
Selection In vitro In vivo In vitro In vivo In vitro In vivo In vitro In vivo In vitro In vivo
R263K
R263K X X X X
M50I/R263K X X
A49G/S230R/R263K X
M50I/S119R/R263K X
H51Y/R263K X
S119R/R263K X
E138K/R263K X
E138AKT/S147G/R263K X
V151I/R263K X
S153Y/R263K X
V260I/R263K X
Other
H51Y/G118R X
V54I X
G59E X
L74M X X X
Q95K X X
T97A X X X
L101Y/T124A/S153Y X
I203M X
H114Y X
G118R X X
F121Y X X X
F121Y/G163R X
F121Y/D232N X
T124A X X X X
T124A/P145S X
T124A/S153F X
T124A/S153Y X
T124A/Q146L X
T125K X
A128T X X
P145S X
Q146L X
Q146P X
S147G X X
V151I X X X X
S153Y X
M154I X
E157Q X
I162M X
G163E X
G163R X
Q177R X
G193E X
S230R X X X

‘X’ marks a report of the selection of a substitution or combination of substitutions. Numbers refer to amino acid position in HIV integrase, one letter amino acid code used

References: [14, 1820, 2853]